Baxdrostat Bioavailability and Bioequivalence Study
Clinical trial NCT05963009 · COMPLETED
Trial details
- NCT number
- NCT05963009
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-11
- Primary completion
- 2020-04-29
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.